Rates of admission for respiratory syncytial virus (RSV) infection in children during their presumed periods of palivizumab prophylaxis
| No of children meeting criteria for prophylaxis | No admitted with RSV during prophylaxis | % admitted with RSV during prophylaxis | |
|---|---|---|---|
| CLD, Chronic lung disease. | |||
| CLD | 25 | 3 | 12.0 |
| ⩽28 weeks | 166 | 8 | 4.8 |
| 29–32 weeks | 395 | 16 | 4.1 |
| Total | 586 | 27 | 4.6 |
CiteULike
Connotea
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
Technorati
Twitter
Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of
ADC Fetal & Neonatal.
View free sample issue >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Online ISSN 1468-2052
Copyright © 2012 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health. All rights reserved.
